Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects

NCT01154634 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux

Interventions

DRUG: AZD2516, 5 mg
DRUG: AZD2516, 16 mg
DRUG: AZD2516, 40 mg
DRUG: Placebo

Sponsor

AstraZeneca